1 – 10 of 265
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Samtycke och beslutskompetens i vården
2025) p.105-120(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Unraveling Cognitive Decline - Integrating Biomarkers of Neurodegeneration, Vascular Pathology, and Neuroinflammation
2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Updated appropriate use criteria for amyloid and tau PET : A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
(
- Contribution to journal › Scientific review
-
Mark
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
(
- Contribution to journal › Article
-
Mark
Cognitive dysfunction in diabetes–the ‘forgotten’ diabetes complication : a narrative review
(
- Contribution to journal › Scientific review
- 2024
-
Mark
In vivo detection of Alzheimer's and Lewy body disease concurrence : Clinical implications and future perspectives
(
- Contribution to journal › Scientific review
-
Mark
Association of MAFLD and MASLD with all-cause and cause-specific dementia : a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Midlife stress-related exhaustion and dementia incidence : a longitudinal study over 50 years in women
(
- Contribution to journal › Article
-
Mark
Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting
(
- Contribution to journal › Article